Advancing Dronabinol Obstructive Sleep Apnea Program with Letter of Intent for Co-Development and Supply Agreement with Noramco, Inc.
June 19, 2018 08:45 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that on June 13, 2018, it entered into a letter...
Huneo Launches SnoreCoach™ Device and SnoreTrack™ App
August 01, 2017 09:00 ET
|
Huneo
CLEVELAND, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Huneo, a biomedical data analytics company, announces the general availability of its SnoreCoach device. SnoreCoach was initially previewed in 2016 in a...